NEW YORK – Antibiotic resistance testing firm Accelerate Diagnostics said on Tuesday that its preliminary Q4 2020 revenue dropped 11 percent year over year.
NEW YORK – Antibiotic resistance testing firm Accelerate Diagnostics said on Tuesday that its preliminary Q4 2020 revenue dropped 11 percent year over year.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.